Ultragenyx Pharmaceutical Inc. — Form 8-K
Filed September 17, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 8/100
What the filing says
Ultragenyx Pharmaceutical filed an 8-K on 2026-09-17 disclosing Item 8.01 (Other Events), but the actual content of those events is not provided in the filing header or metadata. No counterparties, dollar amounts, share counts, dates of transactions, or specific business developments are stated in the available text.
Why this rating
No material information disclosed in this filing; appears to be administrative or boilerplate event notification without substantive details.
Extracted items
See more from September 17, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.